Patents by Inventor Anita Chaudhari
Anita Chaudhari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10889621Abstract: The present invention relates to compositions and methods of use of cupredoxins, and variants, derivatives and structural equivalents of cupredoxins that interfere with the ephrin signaling system in mammalian cells. Specifically, the invention relates to compositions and methods that use cupredoxins, such as azurin, rusticyanin and plastocyanin, and variants, derivatives and structural equivalents thereof, to treat cancer in mammals.Type: GrantFiled: April 26, 2018Date of Patent: January 12, 2021Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOISInventors: Ananda Chakrabarty, Tapas Das Gupta, Tohru Yamada, Anita Chaudhari, Arsenio Fialho, Yonghua Zhu
-
Patent number: 10772879Abstract: This invention relates to pharmaceutical formulations comprising 1-(2-thien-2?-yl-2-oxo-ethyl)-3-(methanesulfonyl hydrazine carbonyl) pyridinium, its pharmaceutically acceptable salts, salt-cocrystals and co-crystals, particularly 1-(2-thien-2?-yl-2-oxo-ethyl)-3-5(methanesulfonyl hydrazine carbonyl) pyridinium chloride. The formulations are suitable for oral administration and also comprise a permeability enhancer or a suitable base or a mixture thereof. The formulations of this invention are for treating diseases associated with advanced glycation end products.Type: GrantFiled: April 5, 2016Date of Patent: September 15, 2020Assignee: Torrent Pharmaceuticals LimitedInventors: Chaitanya Dutt, Jaya Abraham, Vivek Mishra, Amit Kesarwani, Ramesh Chandra Gupta, Shailesh Deshpande, Shital Kumar Zambad, Anoop Mathur, Jignesh Kotecha, Sachin Latad, Manish Patel, Anita Chaudhari
-
Patent number: 10717727Abstract: The present invention relates to novel pyridinium compounds, their isomers, steroisomers, atropisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses process for preparing novel compounds and pharmaceutical composition of said compounds. The invention further relates to the use of the above mentioned compounds for the preparation of medicament for use as pharmaceuticals.Type: GrantFiled: February 4, 2019Date of Patent: July 21, 2020Assignee: Torrent Pharmaceuticals LimitedInventors: Chaitanya Dutt, Rameshchandra Gupta, Manish Patel, Jaya Abraham, Vivek Mishra, Amit Kesarwani, Shailesh Deshpande, Shital Kumar Zambad, Anoop Mathur, Jignesh Kotecha, Sachin Latad, Anita Chaudhari
-
Publication number: 20190169175Abstract: The present invention relates to novel pyridinium compounds, their isomers, steroisomers, atropisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses process for preparing novel compounds and pharmaceutical composition of said compounds. The invention further relates to the use of the above mentioned compounds for the preparation of medicament for use as pharmaceuticals.Type: ApplicationFiled: February 4, 2019Publication date: June 6, 2019Applicant: TORRENT PHARMACEUTICALS LIMITEDInventors: Chaitanya DUTT, Rameshchandra GUPTA, Manish PATEL, Jaya ABRAHAM, Vivek MISHRA, Amit KESARWANI, Shailesh DESHPANDE, Shital Kumar ZAMBAD, Anoop MATHUR, Jignesh KOTECHA, Sachin LATAD, Anita CHAUDHARI
-
Patent number: 10266868Abstract: The present invention relates to cupredoxin, specifically Pseudomonas aeruginosa azurin, and/or Pseudomonas aeruginosa cytochrome c551 and their use in inhibiting of viral infection, and in particular infection of mammalian cells by the Human Immunodeficiency Virus (HIV). The invention also relates to variants and derivatives of cupredoxin and cytochrome c that retain the ability to inhibit viral infection, and in particular infection by the Human Immunodeficiency Virus (HIV). The invention also relates to research methods for studying viral and bacterial infection in mammalian cells.Type: GrantFiled: September 13, 2010Date of Patent: April 23, 2019Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOISInventors: Ananda Chakrabarty, Tapas Das Gupta, Tohru Yamada, Anita Chaudhari, Arsenio Fialho, Chang Soo Hong
-
Patent number: 10233175Abstract: The present invention relates to novel pyridinium compounds, their isomers, steroisomers, atropisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses process for preparing novel compounds and pharmaceutical composition of said compounds. The invention further relates to the use of the above mentioned compounds for the preparation of medicament for use as pharmaceuticals.Type: GrantFiled: April 5, 2016Date of Patent: March 19, 2019Assignee: Torrent Pharmaceuticals LimitedInventors: Chaitanya Dutt, Rameshchandra Gupta, Manish Patel, Jaya Abraham, Vivek Mishra, Amit Kesarwani, Shailesh Deshpande, Shital Kumar Zambad, Anoop Mathur, Jignesh Kotecha, Sachin Latad, Anita Chaudhari
-
Publication number: 20180319847Abstract: The present invention relates to compositions and methods of use of cupredoxins, and variants, derivatives and structural equivalents of cupredoxins that interfere with the ephrin signaling system in mammalian cells. Specifically, the invention relates to compositions and methods that use cupredoxins, such as azurin, rusticyanin and plastocyanin, and variants, derivatives and structural equivalents thereof, to treat cancer in mammals.Type: ApplicationFiled: April 26, 2018Publication date: November 8, 2018Applicant: The Board of Trustees of the University of Illinoi sInventors: Ananda Chakrabarty, Tapas Das Gupta, Tohru Yamada, Anita Chaudhari, Arsenio Fialho, Yonghua Zhu
-
Patent number: 10058585Abstract: The present invention relates to compositions and methods of use of cupredoxins, and variants, derivatives and structural equivalents of cupredoxins that interfere with the ephrin signaling system in mammalian cells. Specifically, the invention relates to compositions and methods that use cupredoxins, such as azurin, rusticyanin and plastocyanin, and variants, derivatives and structural equivalents thereof, to treat cancer in mammals. The invention specifically includes mutants with altered Eph binding constants and selectivities.Type: GrantFiled: August 3, 2015Date of Patent: August 28, 2018Inventors: Anita Chaudhari, Ananda Chakrabarty, Tapas Das Gupta, Arsenio Fialho, Tohru Yamada, Yonghua Zhu
-
Publication number: 20180118728Abstract: The present invention relates to novel pyridinium compounds, their isomers, steroisomers, atropisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses process for preparing novel compounds and pharmaceutical composition of said compounds. The invention further relates to the use of the above mentioned compounds for the preparation of medicament for use as pharmaceuticals.Type: ApplicationFiled: April 5, 2016Publication date: May 3, 2018Applicant: TORRENT PHARMACEUTICALS LIMITEDInventors: Chaitanya DUTT, Rameshchandra GUPTA, Manish PATEL, Jaya ABRAHAM, Vivek MISHRA, Amit KESARWANI, Shailesh DESHPANDE, Shital Kumar ZAMBAD, Anoop MATHUR, Jignesh KOTECHA, Sachin LATAD, Anita CHAUDHARI
-
Patent number: 9957304Abstract: The present invention relates to compositions and methods of use of cupredoxins, and variants, derivatives and structural equivalents of cupredoxins that interfere with the ephrin signaling system in mammalian cells. Specifically, the invention relates to compositions and methods that use cupredoxins, such as azurin, rusticyanin and plastocyanin, and variants, derivatives and structural equivalents thereof to treat cancer in mammals.Type: GrantFiled: May 30, 2008Date of Patent: May 1, 2018Inventors: Ananda Chakrabarty, Tapas Das Gupta, Tohru Yamada, Anita Chaudhari, Arsenio Fialho, Yonghua Zhu
-
Publication number: 20180110763Abstract: This invention relates to pharmaceutical formulations comprising 1-(2-thien-2?-yl-2-oxo-ethyl)-3-(methanesulfonyl hydrazine carbonyl) pyridinium, its pharmaceutically acceptable salts, salt-cocrystals and co-crystals, particularly 1-(2-thien-2?-yl-2-oxo-ethyl)-3-5(methanesulfonyl hydrazine carbonyl) pyridinium chloride. The formulations are suitable for oral administration and also comprise a permeability enhancer or a suitable base or a mixture thereof.Type: ApplicationFiled: April 5, 2016Publication date: April 26, 2018Applicant: TORRENT PHARMACEUTICALS LIMITEDInventors: Chaitanya DUTT, Jaya ABRAHAM, Vivek MISHRA, Amit KESARWANI, Ramesh Chandra GUPTA, Shailesh DESHPANDE, Shital Kumar ZAMBAD, Anoop MATHUR, Jignesh KOTECHA, Sachin LATAD, Manish PATEL, Anita CHAUDHARI
-
Publication number: 20160151452Abstract: The present invention relates to compositions and methods of use of cupredoxins, and variants, derivatives and structural equivalents of cupredoxins that interfere with the ephrin signaling system in mammalian cells. Specifically, the invention relates to compositions and methods that use cupredoxins, such as azurin, rusticyanin and plastocyanin, and variants, derivatives and structural equivalents thereof, to treat cancer in mammals. The invention specifically includes mutants with altered Eph binding constants and selectivities.Type: ApplicationFiled: August 3, 2015Publication date: June 2, 2016Inventors: Anita Chaudhari, Ananda Chakrabarty, Tapas Das Gupta, Arsenio Fialho, Tohru Yamada, Yonghua Zhu
-
Patent number: 9096663Abstract: The present invention relates to compositions and methods of use of cupredoxins, and variants, derivatives and structural equivalents of cupredoxins that interfere with the ephrin signaling system in mammalian cells. Specifically, the invention relates to compositions and methods that use cupredoxins, such as azurin, rusticyanin and plastocyanin, and variants, derivatives and structural equivalents thereof, to treat cancer in mammals. The invention specifically includes mutants with altered Eph binding constants and selectivities.Type: GrantFiled: January 11, 2008Date of Patent: August 4, 2015Assignee: The Board of Trustees of the University of IllinoisInventors: Anita Chaudhari, Ananda Chakrabarty, Tapas Das Gupta, Arsenio Fialho, Tohru Yamada, Yonghua Zhu
-
Publication number: 20150126530Abstract: The present invention relates to novel substituted imidazo[1,2-a]pyrimidine compounds of formula (I), their pharmaceutically acceptable salts, and their isomers, stereoisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses pharmaceutically acceptable compositions of said compounds and process for preparing novel compounds. The invention further” relates to the use of the above-mentioned compounds for the preparation of medicament for use as pharmaceuticals. (Formula I).Type: ApplicationFiled: October 15, 2012Publication date: May 7, 2015Applicant: Torrent Pharmaceuticals LimitedInventors: Chaitanya Dutt, Vijay Chauthaiwale, Ramesh Chandra Gupta, Sameer Ghalsasi, Davinder Tuli, Shailesh Deshpande, Anita Chaudhari, Shitalkumar Zambad
-
Patent number: 8822484Abstract: The present invention relates to novel compounds, their pharmaceutically acceptable salts, and their isomers, steroisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses pharmaceutically acceptable compositions of said compounds and process for preparing novel compounds. The invention further relates to the use of the above-mentioned compounds for the preparation of medicament for use as pharmaceuticals.Type: GrantFiled: August 9, 2013Date of Patent: September 2, 2014Assignee: Torrent Pharmaceuticals LimitedInventors: Sanjay Srivastava, Laxmikant Chhipa, Ramesh Chandra Gupta, Shailesh Deshpande, Anita Chaudhari, Anookh Mohanan, Chaitanya Dutt, Vijay Chauthaiwale, Murali Badanthadka, Prashant G. Jamadarkhana
-
Patent number: 8623816Abstract: The present invention relates to cupredoxin and cytochrome and their use, separately or together, to inhibit the spread of parasitemia in mammalian red blood cells and other tissues infected by the malaria parasite, and in particular the parasitemia of human red blood cells by P. falciparum. The invention provides isolated peptides that are variants, derivatives or structural equivalents of cupredoxins or cytochrome c, and compositions comprising cupredoxins and/or cytochrome c, or variants, derivatives or structural equivalents thereof, that are useful for treating or preventing malaria infection in mammals. Further, the invention provides methods to treat mammalian patients to prevent or inhibit the growth of malarial infection in mammals. The invention also provides methods to prevent the growth of malaria infection in insect vectors.Type: GrantFiled: September 26, 2007Date of Patent: January 7, 2014Assignee: The Board of Trustees of the University of IllinoisInventors: Ananda Chakrabarty, Tapas Das Gupta, Tohru Yamada, Anita Chaudhari, Arsenio Fialho, Chang Soo Hong
-
Publication number: 20130331406Abstract: The present invention relates to novel compounds, their pharmaceutically acceptable salts, and their isomers, steroisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses pharmaceutically acceptable compositions of said compounds and process for preparing novel compounds. The invention further relates to the use of the above-mentioned compounds for the preparation of medicament for use as pharmaceuticals.Type: ApplicationFiled: August 9, 2013Publication date: December 12, 2013Applicant: Torrent Pharmaceuticals LimitedInventors: Sanjay SRIVASTAVA, Laxmikant CHHIPA, Ramesh Chandra GUPTA, Shailesh DESHPANDE, Anita CHAUDHARI, Anookh MOHANAN, Chaitanya DUTT, Vijay CHAUTHAIWALE, Murali BADANTHADKA, Prashant G. JAMADARKHANA
-
Patent number: 8541430Abstract: The present invention relates to novel compounds, their pharmaceutically acceptable salts, and their isomers, stereoisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses pharmaceutically acceptable compositions of said compounds and process for preparing novel compounds. The invention further relates to the use of the above-mentioned compounds for the preparation of medicament for use as pharmaceuticals.Type: GrantFiled: September 8, 2010Date of Patent: September 24, 2013Assignee: Torrent Pharmaceuticals LimitedInventors: Sanjay Srivastava, Laxmikant Chhipa, Ramesh Chandra Gupta, Shailesh Deshpande, Anita Chaudhari, Anookh Mohanan, Chaitanya Dutt, Vijay Chauthaiwale, Murali Badanthadka, Prashant G. Jamadarkhana
-
Publication number: 20110130414Abstract: The present invention relates to novel compounds, their pharmaceutically acceptable salts, and their isomers, stereoisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses pharmaceutically acceptable compositions of said compounds and process for preparing novel compounds. The invention further relates to the use of the above-mentioned compounds for the preparation of medicament for use as pharmaceuticals.Type: ApplicationFiled: September 8, 2010Publication date: June 2, 2011Applicant: TORRENT PHARMACEUTICALS LIMITEDInventors: Sanjay Srivastava, Laxmikant Chhipa, Ramesh Chandra Gupta, Shailesh Deshpande, Anita Chaudhari, Anookh Mohanan, Chaitanya Dutt, Vijay Chauthaiwale, Murali Badanthadka, Prashant G. Jamadarkhana
-
Publication number: 20110070217Abstract: The present invention relates to cupredoxin, specifically Pseudomonas aeruginosa azurin, and/or Pseudomonas aeruginosa cytochrome c551 and their use in inhibiting of viral infection, and in particular infection of mammalian cells by the Human Immunodeficiency Virus (HIV). The invention also relates to variants and derivatives of cupredoxin and cytochrome c that retain the ability to inhibit viral infection, and in particular infection by the Human Immunodeficiency Virus (HIV). The invention also relates to research methods for studying viral and bacterial infection in mammalian cells.Type: ApplicationFiled: September 13, 2010Publication date: March 24, 2011Inventors: ANANDA CHAKRABARTY, TAPAS DAS GUPTA, TOHRU YAMADA, ANITA CHAUDHARI, ARSENIO FIALHO, CHANG SOO HONG